Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cryosite Limited (AU:CTE)
ASX:CTE
Cryosite Limited (CTE) Share Price & Analysis
3 Followers
CTE Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.45 - AU$1.00
Previous CloseAU$0.85
Volume6.00
Average Volume (3M)56.69K
Market Cap
AU$41.49M
Enterprise ValueAU$37.00M
Total Cash (Recent Filing)AU$5.34M
Total Debt (Recent Filing)AU$849.76K
Price to Earnings (P/E)26.3
Beta0.12
Next Earnings
Aug 23, 2024EPS EstimateN/A
Last Dividend Ex-Date
Feb 21, 2024Dividend Yield7.65%
Share Statistics
EPS (TTM)0.03
Shares Outstanding48,809,563
10 Day Avg. Volume81,562
30 Day Avg. Volume56,686
Standard Deviation0.25
R-Squared0.00048
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Cryosite Limited News
PremiumCompany Announcements
Cryosite Limited Shares Company Update
PremiumCompany Announcements
Cryosite Limited Announces Growth and New Director
PremiumCompany Announcements
Cryosite Investor’s Voting Power Surges
PremiumCompany Announcements
Cryosite Director Bolsters Stake with Off-Market Buy
PremiumCompany Announcements
Cryosite Stakeholder Sells Shares, Reduces Voting PowerPremiumCompany Announcements
Cryosite Director Sells Shares Off-MarketOptions Prices
Currently, No data available
---
Ownership Overview
72.25% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
27.75% Public Companies and
Individual Investors
CTE FAQ
What was Cryosite Limited’s price range in the past 12 months?
Cryosite Limited lowest share price was AU$0.45 and its highest was AU$1.00 in the past 12 months.
What is Cryosite Limited’s market cap?
Currently, no data Available
When is Cryosite Limited’s upcoming earnings report date?
Cryosite Limited’s upcoming earnings report date is Aug 23, 2024 which is in 96 days.
How were Cryosite Limited’s earnings last quarter?
Cryosite Limited released its earnings results on Feb 22, 2024. The company reported AU$0.017 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.017.
Is Cryosite Limited overvalued?
According to Wall Street analysts Cryosite Limited’s price is currently Overvalued.
Does Cryosite Limited pay dividends?
Cryosite Limited pays a Annually dividend of AU$0.05 which represents an annual dividend yield of 7.65%. See more information on Cryosite Limited dividends here
What is Cryosite Limited’s EPS estimate?
Cryosite Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cryosite Limited have?
Cryosite Limited has 48,809,563 shares outstanding.
What happened to Cryosite Limited’s price movement after its last earnings report?
Cryosite Limited reported an EPS of AU$0.017 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cryosite Limited?
Currently, no hedge funds are holding shares in AU:CTE
---
Cryosite Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
27.81%
12-Months-Change
Fundamentals
Return on Equity
63.72%
Trailing 12-Months
Asset Growth
8.14%
Trailing 12-Months
Company Description
Cryosite Limited
Cryosite Ltd is engaged in the provision of supply chain logistics, management of pharmaceutical products used in clinical trials. The company's operating segment includes Cord Blood and Tissue Storage and Clinical Trials and Biological Services Logistics. It generates maximum revenue from the Clinical Trials and Biological Services Logistics segment. Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological services.
---
Technical Analysis
---